Pfizer Ranked as Leading Company in Asia for Covid-19 Response and Patient-Centric Approach
Karachi, August 25, 2022 (PPI-OT):Pfizer has been ranked first in its Covid-19 response, patient centricity, patient safety, and bringing innovative, high-quality products amongst pharma companies in Asia in the ‘Corporate Reputation of Pharma’ survey by patient groups across the APAC region. Overall, the company is ranked second for its corporate reputation across Asian countries. Pfizer…
Read More